Search

everythinglearnresearchcommunity

for

Search:↓

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Low zinc levels may be linked to the return of gynecologic cancers.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.

Finasteride does not prevent bladder cancer.

Scalp hypothermia can prevent chemotherapy-induced hair loss but is not suitable for all patients, and more research is needed to improve prevention methods.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Low-dose radiation therapy may improve brain function in some Alzheimer's patients and is generally well-tolerated.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

The study found that horizontal sections of scalp biopsies are better for analyzing hair loss, showing fewer hairs and more fine hairs in balding areas.

Docetaxel and oxaliplatin are effective and have manageable side effects for recurrent platinum-sensitive ovarian cancer.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

The article concludes that hair transplantation is advancing, but a reliable way to ensure complete tumor removal is still needed.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.

Facelifts can lead to high patient satisfaction and a quick recovery when done correctly.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Oral minoxidil may help hair regrowth in female cancer survivors.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.